Finger tapping test and Parkinson’sLearn More
Diagnosis of Parkinson’s can be difficult to confirm by conventional assessments – relying on the judgement of a clinician observing and rating a patient’s movements, or costly brain scans.
Finger Tapping May Differentiate Parkinson’s From Essential TremorLearn More
Essential tremor (ET) is a neurological disorder that causes involuntary and rhythmic shaking.
Parkinson’s and statins: PD-Monitor in clinical studyLearn More
ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s.
Living with Parkinson’s: Using the LID-MonitorLearn More
Levodopa is one of the main medications used to treat symptoms of Parkinson’s. As Parkinson’s progresses the doses of levodopa needed to maintain control over symptoms increases.
What is levodopa-induced dyskinesia?Learn More
Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine.
Partners Wanted to Accelerate Development of Mild Cognitive Impairment Diagnostic DeviceLearn More
ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia.
How drawing on an iPad could lead to Alzheimer’s diagnosisLearn More
Complex figure tests are widely used neuropsychological tests where participants are asked to reproduce a complicated line drawing, first by copying it freehand and then drawing it from memory.
LID-Monitor to also ‘manage bradykinesia’ // China studyLearn More
Pair text with an image to focus on your chosen product, collection, or blog post. Add details on availability, style, or even provide a review.
Global recognition for ClearSky Medical DiagnosticsLearn More
ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology.
SCOR Innovation Podcast: Interview with Professor SmithLearn More
ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast.
‘Lifesaver’ Smith recognised for Parkinson’s researchLearn More
Professor Stephen Smith has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s.
Dr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October.